Your browser doesn't support javascript.
loading
Study on the mechanism and pharmacokinetics of HB-NC4 based on C5b-9 target in the treatment of osteoarthritis.
Rongrong, Chai; Xueting, Yu; Lian, Li; Qiang, Wei; Guangjun, Jiao; Ying, Li; Chen, Yu; Yanling, Mu; Qingqiang, Yao; Yan, Li; Fuwen, Wang.
Affiliation
  • Rongrong C; School of Pharmacy and Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, NHC Key Laboratory of biotechnology drugs (Shandong Academy of Medical Sciences), Key Lab for Rare & Uncommon Diseases of Shandong Provi
  • Xueting Y; School of Pharmacy and Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, NHC Key Laboratory of biotechnology drugs (Shandong Academy of Medical Sciences), Key Lab for Rare & Uncommon Diseases of Shandong Provi
  • Lian L; School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, Shandong, China.
  • Qiang W; Department of Physical Education, Tangshan Normal University, Tangshan 063000, Hebei, China.
  • Guangjun J; Qilu Hospital, Shandong University, Jinan 250012, Shandong, China.
  • Ying L; School of Pharmacy and Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, NHC Key Laboratory of biotechnology drugs (Shandong Academy of Medical Sciences), Key Lab for Rare & Uncommon Diseases of Shandong Provi
  • Chen Y; School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, Shandong, China.
  • Yanling M; School of Pharmacy and Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, NHC Key Laboratory of biotechnology drugs (Shandong Academy of Medical Sciences), Key Lab for Rare & Uncommon Diseases of Shandong Provi
  • Qingqiang Y; School of Pharmacy and Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, NHC Key Laboratory of biotechnology drugs (Shandong Academy of Medical Sciences), Key Lab for Rare & Uncommon Diseases of Shandong Provi
  • Yan L; School of Pharmacy and Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, NHC Key Laboratory of biotechnology drugs (Shandong Academy of Medical Sciences), Key Lab for Rare & Uncommon Diseases of Shandong Provi
  • Fuwen W; School of Pharmacy and Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, NHC Key Laboratory of biotechnology drugs (Shandong Academy of Medical Sciences), Key Lab for Rare & Uncommon Diseases of Shandong Provi
Biochim Biophys Acta Mol Basis Dis ; 1869(5): 166699, 2023 06.
Article in En | MEDLINE | ID: mdl-36965677
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoarthritis / Complement Membrane Attack Complex Limits: Aged / Humans / Middle aged Language: En Journal: Biochim Biophys Acta Mol Basis Dis Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoarthritis / Complement Membrane Attack Complex Limits: Aged / Humans / Middle aged Language: En Journal: Biochim Biophys Acta Mol Basis Dis Year: 2023 Document type: Article Country of publication: